 | Up a level |
Menghrajani, Kamal; Gomez-Arteaga, Alexandra; Madero-Marroquin, Rafael; Zhang, Mei-Jie; Bo-Subait, Khalid; Sanchez, Jonathan; Wang, Hai-Lin; Aljurf, Mahmoud; Assal, Amer; Bacher, Ulrike; Badawy, Sherif M; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Christopher N; Byrne, Michael; Castillo, Paul; Cerny, Jan; Chhabra, Saurabh; Ciurea, Stefan Octavian; DeFilipp, Zachariah; ... (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances, 6(3), pp. 828-847. American Society of Hematology 10.1182/bloodadvances.2021004881
Metheny, Leland; Callander, Natalie S; Hall, Aric C; Zhang, Mei-Jei; Bo-Subait, Khalid; Wang, Hai-Lin; Agrawal, Vaibhav; Al-Homsi, A Samer; Assal, Amer; Bacher, Ulrike; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Chris; Byrne, Michael; Cairo, Mitchell; Cerny, Jan; DeFilipp, Zachariah; Perez, Miguel Angel Diaz; Freytes, César O; ... (2021). Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults. Transplantation and cellular therapy, 27(11), 923.e1-923.e12. Elsevier 10.1016/j.jtct.2021.08.010
Bejanyan, Nelli; Zhang, Meijie; Bo-Subait, Khalid; Brunstein, Claudio; Wang, Hailin; Warlick, Erica D; Giralt, Sergio; Nishihori, Taiga; Martino, Rodrigo; Passweg, Jakob; Dias, Ajoy; Copelan, Edward; Hale, Gregory; Gale, Robert Peter; Solh, Melhem; Kharfan-Dabaja, Mohamed A; Diaz, Miguel Angel; Ganguly, Siddhartha; Gore, Steven; Verdonck, Leo F; ... (2021). Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study. Biology of blood and marrow transplantation, 27(1), 68.e1-68.e9. Elsevier 10.1016/j.bbmt.2020.09.026
